新斯的明联合阿托品治疗硬脊膜穿刺后头痛的随机对照试验
这项随机双盲对照试验纳入85例硬脊膜穿刺后头痛(PDPH)患者,在常规水化与镇痛基础上比较新斯的明联合阿托品与生理盐水安慰剂。结果显示联合治疗组各时间点视觉模拟评分显著优于安慰剂组,且无需硬膜外血补片,但腹部绞痛、肌肉抽搐和膀胱过度活动等并发症仅见于联合治疗组。
要点
- 新斯的明联合阿托品可显著改善PDPH患者各时间点VAS评分。
- 联合治疗组无需硬膜外血补片,安慰剂组有7例(15.9%)需要。
- 联合治疗组出现腹部绞痛、肌肉抽搐和膀胱过度活动等并发症。
核心结论
- 新斯的明联合阿托品仅需不超过2剂即可有效治疗硬脊膜穿刺后头痛。
研究设计与样本
- 随机、对照、双盲研究,比较新斯的明联合阿托品组(n=41)与生理盐水安慰剂组(n=44),共85例PDPH患者,均在常规水化与镇痛基础上给药。
主要发现
- 干预后6、12、24、36、48和72小时,新斯的明联合阿托品组视觉模拟评分均显著优于安慰剂组(P< .001)。
- 新斯的明联合阿托品组无患者需要硬膜外血补片,安慰剂组有7例(15.9%)需要(P< .001)。
- 患者接受新斯的明联合阿托品不超过2剂。
- 两组在颈部僵硬、恶心和呕吐方面无差异。
- 腹部绞痛、肌肉抽搐和膀胱过度活动等并发症仅见于新斯的明联合阿托品组(P< .001)。
关键数值与推荐
- 新斯的明剂量为20 μg/kg,阿托品剂量为10 μg/kg,或等体积生理盐水。
- 主要结局为干预后6、12、24、36、48和72小时视觉模拟评分≤3。
临床怎么用
- 对于常规水化与镇痛效果不佳的PDPH患者,可考虑加用新斯的明联合阿托品,但需警惕腹部绞痛、肌肉抽搐和膀胱过度活动等并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postdural puncture headache (PDPH) lacks a standard evidence-based treatment. A patient treated with neostigmine for severe PDPH prompted this study. METHODS: This randomized, controlled, double-blind study compared neostigmine and atropine (n = 41) versus a saline placebo (n = 44) for treating PDPH in addition to conservative management of 85 patients with hydration and analgesics. The primary outcome was a visual analog scale score of ≤3 at 6, 12, 24, 36, 48, and 72 hours after intervention. Secondary outcomes were the need for an epidural blood patch, neck stiffness, nausea, and vomiting. Patients received either neostigmine 20 μg/kg and atropine 10 μg/kg or an equal volume of saline. RESULTS: Visual analog scale scores were significantly better (P< .001) with neostigmine/atropine than with saline treatment at all time intervals after intervention. No patients in the neostigmine/atropine group needed epidural blood patch compared with 7 (15.9%) in the placebo group (P< .001). Patients required no >2 doses of neostigmine/atropine. There were no between-group differences in neck stiffness, nausea, or vomiting. Complications including abdominal cramps, muscle twitches, and urinary bladder hyperactivity occurred only in the neostigmine/atropine group (P< .001). CONCLUSIONS: Neostigmine/atropine was effective in treating PDPH after only 2 doses. Neostigmine can pass the choroid plexus but not the blood-brain barrier. The central effects of both drugs influence both cerebrospinal fluid secretion and cerebral vascular tone, which are the primary pathophysiological changes in PDPH. The results are consistent with previous studies and clinical reports of neostigmine activity.
引用
- Abdelaal Ahmed Mahmoud A, Mansour AZ, Yassin HM, et al. Addition of Neostigmine and Atropine to Conventional Management of Postdural Puncture Headache: A Randomized Controlled Trial. Anesth Analg. 2018. PMID: 30169405. doi:10.1213/ANE.0000000000003734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。